Literature DB >> 21228059

Frequency and risk factors of gout flares in a large population-based cohort of incident gout.

Dietrich Rothenbacher1, Paola Primatesta, Alberto Ferreira, Lucía Cea-Soriano, Luis A García Rodríguez.   

Abstract

OBJECTIVE: So far, few data are available to characterize the flare history of patients with gout. The objective of this study was to describe the frequency and risk factors of gout flares with special consideration of the comorbidity.
METHODS: A cohort study was conducted in a U.K. general practice database (The Health Improvement Network) including all patients aged 20-89 years diagnosed with incident gout between the years 2000 and 2007.
RESULTS: In this study, 23 857 incident gout patients (mean age 61.9 years) were included, overall incidence rate was 2.68 (95% CI 2.65, 2.72) per 1000 person-years. The proportion of patients with at least one flare during the follow-up period (mean 3.8 years) was 36.9% (n=8806). A history of ischaemic heart disease [hazard ratio (HR) 1.12 (95% CI 1.06, 1.19)], hypertension [HR 1.15 (95% CI 1.10, 1.20)] and renal failure [HR 1.33 (95% CI 1.20, 1.48)] were independently associated with a higher risk of a first gout flare. Use of allopurinol at initial gout diagnosis was associated with a lower risk [HR 0.80 (95% CI 0.75, 0.85)].
CONCLUSIONS: Gout flares are relatively common among patients with gout. Some of the underlying cardiometabolic comorbid conditions are themselves independent risk factors for flares, which further contribute to the complexity of treatment of gout flares.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228059     DOI: 10.1093/rheumatology/keq363

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  29 in total

Review 1.  [Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Authors:  U Kiltz; R Alten; M Fleck; K Krüger; B Manger; U Müller-Ladner; H Nüßlein; M Reuss-Borst; A Schwarting; H Schulze-Koops; A Tausche; J Braun
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

2.  Allopurinol use in a New Zealand population: prevalence and adherence.

Authors:  Simon Horsburgh; Pauline Norris; Gordon Becket; Bruce Arroll; Peter Crampton; Jacqueline Cumming; Shirley Keown; Peter Herbison
Journal:  Rheumatol Int       Date:  2014-01-04       Impact factor: 2.631

3.  Validation of claims-based algorithms for gout flares.

Authors:  Lindsey A MacFarlane; Chih-Chin Liu; Daniel H Solomon; Seoyoung C Kim
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-05-27       Impact factor: 2.890

4.  Changes in the Presentation of Incident Gout and the Risk of Subsequent Flares: A Population-based Study over 20 Years.

Authors:  Mohanad M Elfishawi; Nour Zleik; Zoran Kvrgic; Clement J Michet; Cynthia S Crowson; Eric L Matteson; Tim Bongartz
Journal:  J Rheumatol       Date:  2019-07-15       Impact factor: 4.666

5.  Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout.

Authors:  Edoardo Cipolletta; Laila J Tata; Georgina Nakafero; Anthony J Avery; Mamas A Mamas; Abhishek Abhishek
Journal:  JAMA       Date:  2022-08-02       Impact factor: 157.335

6.  Managing Gout Flares in the Elderly: Practical Considerations.

Authors:  Abhishek Abhishek
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

7.  Demographic and clinical features of gout patients in Turkey: a multicenter study.

Authors:  Mehmet Akif Öztürk; Arif Kaya; Soner Şenel; Salim Dönmez; Ayşe Balkarlı; Veli Çobankara; Çiğdem Erhan; Mehmet Sayarlıoğlu; Yunus Ugan; Ş Ercan Tunç; Yavuz Pehlivan; Bünyamin Kısacık; Abdurrahman Tufan; Ahmet Mesut Onat; Engin Tezcan; Gözde Yıldırım Çetin; Omer Nuri Pamuk
Journal:  Rheumatol Int       Date:  2012-05-16       Impact factor: 2.631

Review 8.  Epidemiology of gout.

Authors:  Edward Roddy; Hyon K Choi
Journal:  Rheum Dis Clin North Am       Date:  2014-02-19       Impact factor: 2.670

9.  Acute Calcium Pyrophosphate Crystal Arthritis Flare Rate and Risk Factors for Recurrence.

Authors:  Katherine A Yates; Kazuki Yoshida; Chang Xu; Houchen Lyu; Vibeke Norvang; Daniel H Solomon; Sara K Tedeschi
Journal:  J Rheumatol       Date:  2019-11-01       Impact factor: 4.666

10.  Comparison of new-onset gout in adults prescribed chlorthalidone vs. hydrochlorothiazide for hypertension.

Authors:  Liza Wilson; Kavita V Nair; Joseph J Saseen
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-09-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.